better
understand
pathophysiolog
rhinoviru
rv
infect
develop
studi
model
use
organ
cultur
turbin
mucosa
sought
inferior
turbin
mucos
tissu
cultur
use
airliquid
interfac
method
support
gelfoam
soak
cultur
media
appli
mucos
surfac
wash
histolog
chang
evalu
success
rv
infect
assay
seminest
rtpcr
mucos
surfac
fluid
taken
h
incub
intracellular
rv
visual
situ
hybrid
ish
secret
cytokin
cultur
media
quantit
elisa
day
cultur
turbin
mucosa
show
signific
damag
pcr
product
indic
success
rv
infect
detect
mucos
tissu
ish
show
small
number
posit
stain
cell
focal
locat
epitheli
layer
begin
h
infect
secret
cultur
media
infect
mucosa
significantli
greater
media
control
mucosa
result
indic
airliquid
interfac
organ
cultur
turbin
mucosa
could
serv
accept
vitro
model
studi
rv
infect
common
pathogen
associ
viral
upper
respiratori
infect
vri
includ
rhinoviru
rv
coronaviru
influenza
viru
parainfluenza
viru
adenoviru
gwaltney
et
al
among
rv
frequent
caus
common
cold
adult
children
respons
case
greenberg
vri
due
rv
clinic
signific
otolaryngolog
practic
sinc
commonli
preced
predispos
bacteri
rhinosinus
otiti
media
greenberg
pitkaranta
et
al
rv
nonenvelop
nm
rnaviru
belong
picornavirida
famili
greenberg
nasal
nasopharyng
epitheli
cell
primari
target
rv
infect
cell
express
surfac
intercellular
adhes
molecul
icam
low
densiti
lipoprotein
receptor
site
rv
attach
casasnova
springer
follow
attach
rv
receptor
entir
viru
transloc
across
epitheli
cell
membran
uncoat
releas
viral
rna
cytoplasm
replic
rv
infect
trigger
epitheli
cell
product
cytokin
interleukin
il
function
neutrophil
chemoattract
respons
cold
symptom
zhu
et
al
rv
infect
shown
stimul
elabor
cytokin
includ
rant
mip
also
contribut
cascad
inflammatori
reaction
terajima
et
al
yuta
et
al
despit
obviou
medic
import
rv
infect
pathophysiolog
thoroughli
understood
addit
pathogen
mechan
rv
induc
sinus
clear
van
cauwenberg
ingel
better
understand
pathophysiolog
rv
infect
ideal
experiment
model
critic
import
howev
practic
anim
model
studi
rv
infect
yet
avail
therefor
date
studi
rv
infect
mostli
perform
vivo
challeng
volunt
use
nasal
lavag
fluid
infect
mucos
tissu
yuta
et
al
primari
cultur
tracheal
bronchial
epitheli
cell
cultur
transform
cell
line
zhu
et
al
sethi
et
al
howev
method
limit
vivo
challeng
method
associ
ethic
consider
preclud
certain
type
experiment
work
human
cultur
isol
epitheli
cell
probabl
reflect
partial
pictur
inflammatori
respons
mucosa
inasmuch
inflammatori
cell
mast
cell
eosinophil
macrophag
lymphocyt
endotheli
cell
glandular
element
also
involv
entir
rvinduc
inflammatori
process
schierhorn
et
al
furthermor
primari
cultur
tracheal
epitheli
cell
cell
line
lower
respiratori
tract
fulli
reflect
exact
physiolog
chang
occur
nasal
caviti
nasopharynx
mucosa
primari
site
rv
infect
area
interest
pathogenesi
rvinduc
sinus
therefor
need
human
vitro
model
safe
reliabl
physiolog
relev
studi
attempt
overcom
limit
convent
studi
method
author
sought
develop
new
model
rv
infect
sinc
upper
airway
especi
nose
major
target
rv
infect
van
cauwenberg
ingel
hypothes
organ
cultur
model
turbin
mucosa
may
physiolog
relev
author
describ
develop
airinterfac
organ
cultur
system
grow
rv
turbin
mucosa
readili
avail
variou
nasal
surgic
procedur
feasibl
model
examin
confirm
rv
infect
use
seminest
rtpcr
situ
hybrid
ish
measur
secret
marker
inflammatori
respons
rv
infect
inferior
turbin
mucosa
harvest
patient
mean
age
year
rang
year
underw
septoturbinoplasti
treatment
symptomat
nasal
septal
deviat
turbin
five
patient
use
histolog
evalu
effect
cultur
method
integr
tissu
patient
subject
rvinfect
subsequ
seminest
rtpcr
ish
turbin
tissu
five
patient
infect
rv
cultur
media
use
assay
cytokin
secret
subject
histori
uri
previou
month
medic
antihistamin
antibiot
previou
month
paranas
sinus
previou
month
exclud
subject
routin
check
sinu
xray
confirm
absenc
sinu
patholog
presenc
allergi
exclud
skin
prick
test
common
aeroallergen
bencard
tm
bradford
england
subject
sign
inform
consent
form
studi
design
approv
institut
review
board
asan
medic
center
obtain
american
type
cultur
collect
atcc
manassa
va
addit
viral
stock
prepar
infect
c
hela
cell
atcc
lowinput
multipl
infect
moi
infect
notabl
advanc
evidenc
cytopath
effect
cell
supernat
harvest
cell
disrupt
freez
thaw
debri
pellet
lowspe
centrifug
aliquot
clarifi
supernat
frozen
c
determin
viral
titer
inferior
turbin
mucos
tissu
wash
three
time
hepe
buffer
remov
blood
cell
mucu
divid
four
small
piec
mm
biopsi
punch
stiefel
offenbach
germani
place
minim
essenti
medium
mem
gibco
grand
island
ny
supplement
mm
lglutamin
mm
hepe
penicillin
uml
streptomycin
gml
fungizon
gml
h
c
tissu
sampl
implant
airliquid
interfac
epithelium
submucosa
mm
mm
support
gelfoam
johnson
johnson
gargrav
uk
prehydr
least
h
cultur
medium
fig
fragment
place
well
well
plate
nunclon
nunc
roskild
denmark
along
ml
cultur
medium
epithelium
liquid
phase
top
appli
l
tcid
uml
h
follow
sampl
wash
four
time
phosphat
buffer
salin
pb
rvinfect
mucosa
transfer
second
set
ident
plate
incub
addit
h
c
fig
schemat
illustr
organ
cultur
system
use
studi
mucos
piec
place
onto
gelfoam
support
soak
cultur
medium
rhinoviru
appli
apic
surfac
turbin
mucosa
evalu
histolog
chang
turbin
mucosa
organ
cultur
five
mucos
tissu
cultur
day
without
rv
infect
sampl
stain
cultur
hematoxylineosin
h
e
examin
light
microscopi
magnif
histolog
chang
evalu
blind
manner
code
slide
evalu
inform
organ
cultur
rna
extract
mucos
surfac
fluid
use
trizol
reagent
invitrogen
carlsbad
ca
accord
manufactur
protocol
picornaviru
rna
revers
transcrib
amplifi
use
primer
invitrogen
superscript
onestep
rtpcr
platinum
taq
kit
invitrogen
gaithersburg
md
usa
pcr
mixtur
contain
reaction
buffer
mm
dntp
mm
l
primer
l
platinum
taq
mix
l
rna
templat
final
volum
l
pcr
reaction
conduct
thermal
cycler
perkinelm
minneapoli
minnesota
usa
program
initi
cdna
synthesi
predenatur
c
h
c
min
follow
cycl
denatur
c
anneal
c
extens
c
pcr
product
gener
protocol
base
pair
bp
amplificon
region
noncod
region
picornaviru
genom
picornaviru
pcr
product
amplifi
use
primer
pcr
mixtur
contain
reaction
buffer
mm
dntp
mm
l
primer
u
amlitaq
appli
biosystem
forster
citi
ca
l
rtpcr
product
final
volum
l
amplif
protocol
consist
cycl
denatur
c
anneal
c
extens
c
follow
final
extens
min
c
pcr
product
gener
protocol
bp
amplicon
within
origin
amplificon
mucos
tissu
infect
h
rv
follow
incub
h
without
rv
fix
optim
cut
temperatur
compound
solut
slice
thick
slice
mount
glass
slide
dri
min
c
slide
incub
aceton
min
wash
run
water
store
c
subsequ
bought
room
temperatur
incub
depc
min
mm
glycerin
min
slide
wash
pb
min
incub
triton
min
wash
pb
min
slide
incub
proteas
k
oncogen
boston
min
c
wash
pb
min
fix
paraformaldehyd
min
wash
pb
min
mixtur
contain
l
reaction
buffer
potassium
cacodyl
mm
trishcl
mgml
bovin
serum
albumin
ph
l
mm
cocl
l
mm
l
termin
transferas
roch
manheim
germani
mol
oligonucleotid
probe
final
volum
l
centrifug
mix
l
edta
ph
ice
oligonucleotid
probe
use
probe
mix
hybrid
solut
ssc
denhardt
solut
mm
phosphat
buffer
ph
mm
dtt
gml
yeast
trna
gml
polydeoxyadenyl
acid
gml
polyadenyl
acid
formamid
dextran
sulfat
gml
denatur
ss
dna
l
mixtur
drop
onto
mucos
tissu
slide
cover
cover
glass
incub
h
c
slide
immers
ssc
remov
cover
glass
wash
twice
ssc
min
twice
ssc
min
slide
wash
twice
buffer
mm
trishcl
ph
mm
nacl
min
shake
incub
buffer
ii
mm
trishcl
ph
mm
nacl
triton
block
reagent
min
onto
slide
place
antidigalkalin
phosphatas
fab
fragment
dilut
buffer
ii
h
room
temperatur
incub
buffer
iii
mm
trishcl
ph
mm
nacl
mm
min
mixtur
l
nitroblu
tetrazolium
nbt
l
bcip
ml
buffer
iii
place
onto
slide
slide
cover
incub
h
slide
examin
light
microscopi
magnif
ish
result
evalu
blind
manner
code
slide
evalu
inform
rtpcr
result
posit
hybrid
signal
defin
visibl
cytoplasm
reactiv
five
mucos
tissu
divid
five
piec
one
use
control
incub
h
without
rv
applic
remain
four
tissu
infect
rv
h
follow
incub
h
cultur
media
store
c
assay
level
basolater
cultur
media
assay
use
elisa
kit
biosourc
co
nivel
belgium
accord
manufactur
protocol
differ
cytokin
concentr
control
experiment
cultur
analyz
use
wilcoxon
sign
rank
test
p
valu
less
defin
statist
signific
follow
organ
cultur
day
pseudostratifi
columnar
epithelium
turbin
well
preserv
without
obviou
abnorm
epithelium
basement
membran
evid
increas
ciliari
loss
epitheli
ulcer
cultur
evid
infect
turbin
mucosa
subsequ
viral
replic
releas
mucos
surfac
assay
seminest
rtpcr
detect
pcr
product
bp
neg
control
use
distil
water
mucos
surfac
fluid
uninfect
control
tissu
experi
rv
appli
mucos
surfac
h
posit
band
bp
repres
unattach
rv
observ
mucos
surfac
fluid
taken
h
incub
remov
unattach
rv
mucos
surfac
four
time
extens
wash
pb
conduct
posit
band
fourth
wash
fluid
indic
wash
process
complet
remov
remain
unattach
rv
basolater
medium
pb
use
wash
mucos
surfac
h
later
also
assay
rtpcr
evid
bp
band
basolater
medium
indic
rv
contamin
cultur
medium
five
mucos
surfac
wash
fluid
sampl
h
later
reveal
bp
rvspecif
band
indic
cultur
success
infect
rv
cell
subsequ
releas
rv
onto
mucos
surfac
fig
ish
show
evid
rv
infect
control
mucosa
infect
turbin
mucosa
viru
posit
assay
ish
posit
mucosa
howev
low
number
epitheli
cell
ish
posit
cell
focal
locat
interspers
long
stretch
noninfect
epithelium
fig
posit
signal
subepitheli
lamina
propria
layer
begin
h
infect
concentr
cultur
media
infect
mucosa
significantli
greater
media
control
mucosa
p
wicoxon
sign
rank
test
fig
although
organ
cultur
nasal
mucosa
use
variou
research
area
schierhorn
et
al
tsang
et
al
jackson
et
al
limit
number
report
organ
cultur
use
studi
rv
infect
exampl
trachea
cultur
screwcap
tube
incub
roller
drum
hamori
et
al
fragment
epithelium
adher
submucosa
cultur
nasal
polyp
adenoid
nasal
turbin
plastic
dish
winther
et
al
method
use
previou
report
differ
shown
use
trachea
embryon
tissu
use
airliquid
interfac
method
hamori
et
al
winther
et
al
higgin
et
al
merigan
et
al
organ
cultur
submerg
tissu
media
airliquid
interfac
method
better
mimic
physiolog
condit
airliquid
interfac
method
also
vari
accord
matrix
filter
paper
gelfoam
cultur
media
suppli
present
stud
gelfoam
spong
use
nourish
basolater
side
tissu
lift
tissu
surfac
air
schierhorn
et
al
cultur
media
chang
number
cilia
ciliari
beat
frequenc
mitochondria
nuclei
remain
regular
chang
cultur
media
leav
cell
unchang
day
jackson
et
al
present
studi
found
mucosa
could
maintain
intact
week
without
signific
epitheli
ciliari
damag
furthermor
sinc
time
cultur
never
exceed
day
cultur
techniqu
describ
adequ
futur
studi
demonstr
success
viral
infect
replic
epitheli
cell
seminest
rtpcr
surfac
wash
fluid
h
infect
conduct
diagnosi
rv
infect
tradit
made
isol
viru
appropri
specimen
cultur
practic
howev
rv
cultur
requir
sever
day
serolog
test
impract
numer
rv
serotyp
greenberg
contrast
rtpcr
assay
provid
sensit
specif
method
detect
rv
greenberg
pitkaranta
et
al
epitheli
cell
infect
rv
small
fraction
cell
infect
cell
viral
replic
take
place
rv
releas
cell
surfac
allow
detect
surfac
fluid
epitheli
cell
abil
detect
rv
infect
use
seminest
rtpcr
present
studi
differ
convent
method
viral
identif
viral
cultur
fibroblast
although
viral
cultur
titrat
quantit
rv
wherea
rtpcr
latter
rapid
day
versu
week
addit
cell
cultur
method
use
determin
amount
infecti
viru
use
detect
low
level
infecti
viru
myatt
et
al
seminest
rtpcr
howev
highli
sensit
method
detect
rv
myatt
et
al
perform
rtpcr
essenti
complet
wash
unattach
rv
epitheli
cell
h
adsorpt
rv
wash
complet
rtpcr
perform
h
cultur
give
fals
posit
result
author
confirm
extens
wash
cell
complet
remov
rv
conduct
seminest
rtpcr
wash
fluid
studi
also
found
tissu
sampl
show
posit
rtpcr
result
suggest
success
infect
failur
replic
particular
mucos
tissu
sampl
may
due
characterist
strain
prior
immun
donor
turbin
problem
methodolog
vivo
rv
challeng
volunt
howev
everi
volunt
actual
infect
bruce
et
al
exampl
one
studi
show
document
rv
infect
nonallerg
subject
yuta
et
al
thu
find
infect
sampl
posit
rtpcr
may
reflect
vivo
condit
present
studi
order
exclud
effect
mucos
inflamm
evalu
feasibl
organ
cultur
model
subject
allergi
paranas
sinus
vri
exclud
enrol
thu
remain
determin
futur
investig
allergi
sinus
affect
author
turbin
cultur
model
rv
studi
one
concern
mention
turbin
organ
cultur
model
recent
rv
rna
identifi
ish
adenoid
tissu
children
subject
adenoidectomi
rihkanen
et
al
accordingli
chanc
preexist
posit
rv
turbin
tissu
also
present
studi
howev
rv
detect
uninfect
control
tissu
thu
preexist
viral
infect
could
rule
data
avail
far
detect
rate
rv
uninfect
human
turbin
tissu
howev
studi
requir
proper
evalu
feasibl
studi
model
relat
preexist
posit
rv
turbin
mucosa
present
studi
ish
experi
perform
confirm
viral
particl
harbor
epitheli
cell
use
probe
rv
rna
could
found
insid
epitheli
cell
sampl
five
six
turbin
also
posit
rtpcr
find
rv
rna
ish
rtpcr
one
mucosa
line
previou
report
show
ish
slightli
sensit
rtpcr
detect
rv
infect
upper
respiratori
tract
pitkaranta
et
al
sampl
posit
ish
howev
small
fraction
epitheli
cell
posit
cell
focal
locat
interspers
long
stretch
appar
noninfect
epithelium
find
rv
infect
nasal
epithelium
focal
involv
small
number
cell
agreement
evid
vivo
studi
use
viru
isol
ish
studi
nasal
polyp
fragment
infect
ex
vivo
bruce
et
al
arruda
et
al
rv
caus
mark
destruct
epitheli
line
infect
consid
limit
certain
area
nasal
epithelium
pitkaranta
et
al
author
present
studi
use
organ
cultur
model
increas
secret
begin
h
rv
infect
demonstr
amount
secret
use
import
paramet
rvinduc
patholog
yuta
et
al
particular
interest
level
increas
rapidli
parallel
time
cours
nasal
symptom
gern
buss
thu
find
increas
secret
suggest
organ
cultur
model
suitabl
studi
outcom
rv
infect
h
time
lag
agreement
vivo
studi
show
cytokin
secret
increas
second
day
infect
yuta
et
al
conclus
author
describ
use
airliquid
interfac
organ
cultur
method
human
nasal
epithelia
method
close
resembl
nativ
epithelium
primari
target
rv
infect
use
model
author
show
infect
rv
cytokin
respons
similar
vivo
tissu
find
suggest
organ
cultur
model
use
studi
suitabl
studi
rv
pathogenesi
human
respiratori
epithelium
